Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1945 5
1946 6
1947 12
1948 11
1949 12
1950 15
1951 18
1952 23
1953 18
1954 23
1955 27
1956 31
1957 31
1958 15
1959 23
1960 18
1961 17
1962 18
1963 17
1964 30
1965 22
1966 11
1967 13
1968 22
1969 30
1970 15
1971 21
1972 25
1973 17
1974 23
1975 24
1976 20
1977 37
1978 28
1979 33
1980 37
1981 48
1982 56
1983 73
1984 71
1985 66
1986 54
1987 66
1988 72
1989 77
1990 84
1991 81
1992 104
1993 111
1994 143
1995 122
1996 118
1997 120
1998 141
1999 102
2000 141
2001 155
2002 147
2003 158
2004 150
2005 168
2006 185
2007 209
2008 188
2009 191
2010 176
2011 188
2012 194
2013 160
2014 178
2015 206
2016 200
2017 169
2018 189
2019 218
2020 219
2021 229
2022 228
2023 241
2024 190
2025 194
2026 128

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

6,942 results

Results by year

Filters applied: . Clear all
Page 1
Approach to the patient with suspected hypereosinophilic syndrome.
Klion AD. Klion AD. Hematology Am Soc Hematol Educ Program. 2022 Dec 9;2022(1):47-54. doi: 10.1182/hematology.2022000367. Hematology Am Soc Hematol Educ Program. 2022. PMID: 36485140 Free PMC article. Review.
Hypereosinophilic syndromes (HES) are a heterogenous group of rare disorders with clinical manifestations ranging from fatigue to life-threatening endomyocardial fibrosis and thromboembolic events. ...Whereas the recent availability of eosinophil-targeted therapies …
Hypereosinophilic syndromes (HES) are a heterogenous group of rare disorders with clinical manifestations ranging from fatigue …
French guidelines for the etiological workup of eosinophilia and the management of hypereosinophilic syndromes.
Groh M, Rohmer J, Etienne N, Abou Chahla W, Baudet A, Chan Hew Wai A, Chenivesse C, Clisson Rusek I, Cottin V, Decamp M, De Groote P, Delahousse F, Duployez N, Faguer S, Gottrand F, Huang F, Leblanc T, Magnan A, Martin T, Mortuaire G, Néel A, Paris L, Petit A, Rossignol J, Schleinitz N, Soret-Dulphy J, Staumont-Salle D, Terrier B, Terriou L, Viallard JF, Lefèvre G, Kahn JE. Groh M, et al. Orphanet J Rare Dis. 2023 Apr 30;18(1):100. doi: 10.1186/s13023-023-02696-4. Orphanet J Rare Dis. 2023. PMID: 37122022 Free PMC article.
To date, guidelines for the etiological workup and management of eosinophilia are mainly issued by hematologists, and thus mostly cover the scope of clonal hypereosinophilic syndromes (HES). Here, thanks to an extensive literature review, and thanks to the joint wor …
To date, guidelines for the etiological workup and management of eosinophilia are mainly issued by hematologists, and thus mostly cover the …
Hypereosinophilic syndromes in the precision medicine era: clinical, molecular aspects and therapeutic approaches (targeted therapies).
Iurlo A, Cattaneo D, Gianelli U. Iurlo A, et al. Expert Rev Hematol. 2019 Dec;12(12):1077-1088. doi: 10.1080/17474086.2019.1677461. Epub 2019 Oct 15. Expert Rev Hematol. 2019. PMID: 31588817 Review.
Introduction: Hypereosinophilic syndromes are a heterogeneous group of disorders that may be associated with life-threatening organ injury as a result of tissues infiltration by eosinophils. ...However, even in the absence of any known cause, when organ damage is pr …
Introduction: Hypereosinophilic syndromes are a heterogeneous group of disorders that may be associated with life-threatening …
[The Hypereosinophilic Syndromes in Childhood].
Leu T, Simon HU, Hebestreit H, Kunzmann S. Leu T, et al. Klin Padiatr. 2015 Nov;227(6-7):308-13. doi: 10.1055/s-0035-1555792. Epub 2015 Aug 12. Klin Padiatr. 2015. PMID: 26267413 Review. German.
The hypereosinophilic syndromes are rare disorders in childhood and require extensive differential diagnostic considerations. In the last years the earlier "idiopathic HES" called syndromes could be differentiated into molecular biologically, immunophenotypic …
The hypereosinophilic syndromes are rare disorders in childhood and require extensive differential diagnostic considerations. …
Imatinib for the treatment of hypereosinophilic syndromes.
Helbig G. Helbig G. Expert Rev Clin Immunol. 2018 Feb;14(2):163-170. doi: 10.1080/1744666X.2018.1425142. Epub 2018 Jan 9. Expert Rev Clin Immunol. 2018. PMID: 29303368 Review.
Hypereosinophilic syndromes (HES) encompass a group of disorders defined by sustained peripheral blood hypereosinophilia >1500/mm(3) and evidence of eosinophilia-associated organ impairment. ...Expert commentary: Imatinib mesylate, a first generation tyrosine kin …
Hypereosinophilic syndromes (HES) encompass a group of disorders defined by sustained peripheral blood hypereosinophilia >1 …
The hypereosinophilic syndromes: current concepts and treatments.
Gleich GJ, Leiferman KM. Gleich GJ, et al. Br J Haematol. 2009 May;145(3):271-85. doi: 10.1111/j.1365-2141.2009.07599.x. Br J Haematol. 2009. PMID: 19243381 Review.
The hypereosinophilic syndromes (HES) encompass a spectrum of diseases that have increased blood eosinophils and tissue damage in common. ...
The hypereosinophilic syndromes (HES) encompass a spectrum of diseases that have increased blood eosinophils and tissue damage …
Biologic Agents for the Treatment of Hypereosinophilic Syndromes.
Kuang FL, Klion AD. Kuang FL, et al. J Allergy Clin Immunol Pract. 2017 Nov-Dec;5(6):1502-1509. doi: 10.1016/j.jaip.2017.08.001. J Allergy Clin Immunol Pract. 2017. PMID: 29122152 Free PMC article. Review.
Hypereosinophilic syndromes (HES) are a heterogeneous group of rare disorders defined by the presence of marked peripheral or tissue eosinophilia resulting in end-organ damage. ...
Hypereosinophilic syndromes (HES) are a heterogeneous group of rare disorders defined by the presence of marked peripheral or …
The hypereosinophilic syndromes: still more heterogeneity.
Gleich GJ, Leiferman KM. Gleich GJ, et al. Curr Opin Immunol. 2005 Dec;17(6):679-84. doi: 10.1016/j.coi.2005.09.008. Epub 2005 Oct 7. Curr Opin Immunol. 2005. PMID: 16214314 Review.
In 1968, the term hypereosinophilic syndromes (HES) was coined to refer to a spectrum of eosinophil-associated diseases presumed to be caused by an underlying immunological pathology. ...
In 1968, the term hypereosinophilic syndromes (HES) was coined to refer to a spectrum of eosinophil-associated diseases presum …
Clinical management of the hypereosinophilic syndromes.
Cogan E, Roufosse F. Cogan E, et al. Expert Rev Hematol. 2012 Jun;5(3):275-89; quiz 290. doi: 10.1586/ehm.12.14. Expert Rev Hematol. 2012. PMID: 22780208 Review.
Hypereosinophilic syndromes (HESs) are rare disorders characterized by marked hypereosinophilia that is directly responsible for organ damage or dysfunction. ...
Hypereosinophilic syndromes (HESs) are rare disorders characterized by marked hypereosinophilia that is directly responsible f …
Hypereosinophilic Syndrome.
Curtis C, Ogbogu P. Curtis C, et al. Clin Rev Allergy Immunol. 2016 Apr;50(2):240-51. doi: 10.1007/s12016-015-8506-7. Clin Rev Allergy Immunol. 2016. PMID: 26475367 Review.
Hypereosinophilic syndrome consists of a group of disorders characterized by abnormal accumulation of eosinophils in the blood or peripheral tissues, independent of known secondary causes of eosinophilia such as parasitic infection. ...This review will discuss the e …
Hypereosinophilic syndrome consists of a group of disorders characterized by abnormal accumulation of eosinophils in the blood …
6,942 results